HCA Healthcare Inc (NYSE:HCA) Shares Acquired by Point72 Asset Management L.P.
Point72 Asset Management L.P. grew its stake in HCA Healthcare Inc (NYSE:HCA) by 80.0% during the 4th quarter, Holdings Channel reports. The firm owned 183,018 shares of the company’s stock after purchasing an additional 81,333 shares during the quarter. Point72 Asset Management L.P.’s holdings in HCA Healthcare were worth $27,052,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently made changes to their positions in HCA. Penserra Capital Management LLC acquired a new stake in shares of HCA Healthcare in the third quarter valued at about $26,000. Aigen Investment Management LP acquired a new position in shares of HCA Healthcare in the fourth quarter valued at approximately $31,000. Mizuho Securities Co. Ltd. acquired a new position in shares of HCA Healthcare in the fourth quarter valued at approximately $44,000. Patriot Financial Group Insurance Agency LLC grew its holdings in shares of HCA Healthcare by 103.7% in the fourth quarter. Patriot Financial Group Insurance Agency LLC now owns 332 shares of the company’s stock valued at $49,000 after purchasing an additional 169 shares in the last quarter. Finally, TCI Wealth Advisors Inc. grew its holdings in shares of HCA Healthcare by 381.7% in the fourth quarter. TCI Wealth Advisors Inc. now owns 342 shares of the company’s stock valued at $51,000 after purchasing an additional 271 shares in the last quarter. Institutional investors and hedge funds own 70.37% of the company’s stock.
In other HCA Healthcare news, SVP P. Martin Paslick sold 5,167 shares of the business’s stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $150.00, for a total transaction of $775,050.00. Following the completion of the transaction, the senior vice president now owns 12,957 shares in the company, valued at approximately $1,943,550. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Joseph A. Sowell III sold 21,309 shares of the business’s stock in a transaction that occurred on Tuesday, February 4th. The stock was sold at an average price of $145.00, for a total transaction of $3,089,805.00. Following the transaction, the senior vice president now owns 646 shares of the company’s stock, valued at approximately $93,670. The disclosure for this sale can be found here. Insiders have sold a total of 68,004 shares of company stock valued at $9,941,381 in the last quarter. 2.70% of the stock is currently owned by company insiders.
HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, January 28th. The company reported $3.09 EPS for the quarter, hitting the consensus estimate of $3.09. HCA Healthcare had a net margin of 6.83% and a negative return on equity of 242.04%. The company had revenue of $13.52 billion during the quarter, compared to analysts’ expectations of $13.37 billion. During the same quarter in the previous year, the business posted $3.01 EPS. The firm’s revenue was up 10.2% on a year-over-year basis. Analysts forecast that HCA Healthcare Inc will post 11.58 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Monday, March 2nd will be issued a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a yield of 1.86%. The ex-dividend date is Friday, February 28th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.40. HCA Healthcare’s payout ratio is 16.38%.
HCA has been the subject of a number of research reports. SunTrust Banks restated a “buy” rating and issued a $185.00 price objective on shares of HCA Healthcare in a report on Wednesday, January 29th. Deutsche Bank initiated coverage on shares of HCA Healthcare in a report on Friday, January 3rd. They issued a “buy” rating and a $140.00 price objective for the company. Bank of America upgraded shares of HCA Healthcare from a “neutral” rating to a “buy” rating in a report on Friday, December 6th. Credit Suisse Group restated a “buy” rating and issued a $173.00 price objective on shares of HCA Healthcare in a report on Thursday, March 19th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of HCA Healthcare from $157.00 to $186.00 and gave the company an “overweight” rating in a report on Friday, December 20th. Two equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $160.06.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Further Reading: Understanding debt-to-equity ratio in fundamental analysis
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.